Phibro Animal Health (NASDAQ:PAHC) Cut to “Hold” at StockNews.com

StockNews.com downgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a buy rating to a hold rating in a research report sent to investors on Tuesday.

Several other research firms have also recently issued reports on PAHC. Barclays boosted their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research note on Monday, February 10th. Morgan Stanley increased their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Two research analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to data from MarketBeat.com, Phibro Animal Health has an average rating of “Hold” and an average price target of $21.00.

Phibro Animal Health Price Performance

NASDAQ:PAHC opened at $21.51 on Tuesday. The firm’s fifty day moving average is $22.74 and its two-hundred day moving average is $22.67. The firm has a market cap of $871.22 million, a price-to-earnings ratio of 44.81, a PEG ratio of 0.45 and a beta of 0.58. Phibro Animal Health has a one year low of $12.17 and a one year high of $26.55. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Research analysts expect that Phibro Animal Health will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio is presently 100.00%.

Institutional Trading of Phibro Animal Health

Institutional investors have recently modified their holdings of the stock. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Phibro Animal Health during the fourth quarter worth approximately $29,000. Lazard Asset Management LLC grew its holdings in shares of Phibro Animal Health by 2,739.7% during the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company’s stock worth $34,000 after buying an additional 1,589 shares in the last quarter. Quantbot Technologies LP acquired a new stake in shares of Phibro Animal Health in the third quarter valued at about $70,000. Virtus Fund Advisers LLC purchased a new position in shares of Phibro Animal Health in the fourth quarter worth about $69,000. Finally, Aquatic Capital Management LLC acquired a new position in Phibro Animal Health during the fourth quarter worth about $69,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.